Olanzapine versus Risperidone: A Prospective Comparison of Clinical and Economic Outcomes in Schizophrenia

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.18, Iss.6, 2000-12, pp. : 567-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Outcomes Associated with Switching Individuals with Schizophrenia Between Risperidone and Olanzapine: Findings from a Large US Claims Database

By Zhao Z. Namjoshi M. Barber B.L. Loosbrock D.L. Tunis S.L. Zhu B. Breier A.

CNS Drugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 157-164

Adis International

Access to resources Recommend Favorite

Olanzapine versus Risperidone in the Treatment of Schizophrenia: A Comparison of Costs among Texas Medicaid Recipients

By Rascati K.L.

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 683-697

Adis International

Access to resources Recommend Favorite

Olanzapine and risperidone on a par in schizophrenia

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Olanzapine and risperidone on a par in schizophrenia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia: Results From a Randomised Clinical Trial

By Hamilton S.H.

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 469-480

Adis International

Access to resources Recommend Favorite